|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5377 | |
| C07D 471/04 | |||
| A61P 25/24 |
| (11) | Patento numeris | 2854814 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13793417.0 |
| Europos patento paraiškos padavimo data | 2013-05-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/042732 |
| Data | 2013-05-24 |
| (87) | Numeris | WO 2013/177559 |
| Data | 2013-11-28 |
| (30) | Numeris | Data | Šalis |
| 201261651669 P | 2012-05-25 | US | |
| 201261691083 P | 2012-08-20 | US | |
| 201261715907 P | 2012-10-19 | US | |
| 201361759520 P | 2013-02-01 | US | |
| 201361781629 P | 2013-03-14 | US |
| (72) |
HUNT, Hazel, GB
JOHNSON, Tony, GB
RAY, Nicholas, GB
WALTERS, Iain, GB
|
| (73) |
Corcept Therapeutics, Inc.,
149 Commonwealth Drive, Menlo Park CA 94025,
US
|
| (54) | HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |
| HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |